<p>Detailed analysis of randomized-controlled trials evaluating iNO: Inhaled Nitric Oxide (iNO) in neonates.</p
OBJECTIVE. The aim was to determine whether inhaled nitric oxide therapy improves neurodevelopmental...
Ventilated preterm infants frequently develop bronchopulmonary dysplasia (BPD) which is associated w...
Inhaled nitric oxide (iNO) is approved by the Food andDrug Administration for the treatment of persi...
The 21st century began with the FDA approval of inhaled nitric oxide therapy for the treatment of ne...
Aim: To test the hypothesis that inhaled nitric oxide therapy can decrease the incidence of bronchop...
ObjectiveInhaled nitric oxide (iNO) is a potential new therapy for prevention of bronchopulmonary dy...
Background: Respiratory failure in term and near term infants is often associated with persistent pu...
Background: Preterm infants requiring assisted ventilation are at significant risk of both pulmon...
BACKGROUND: Inhaled nitric oxide (iNO) is used widely in newborn infants with hypoxic respiratory fa...
BACKGROUND: Inhaled nitric oxide (iNO) is an effective therapy for pulmonary hypertension and hypoxi...
In animal models, inhaled nitric oxide improved gas exchange and lung structural development, but it...
The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitri...
OBJECTIVE. We compared serial measurements of inflammatory mediators and markers in infants treated ...
Objective—To report the neurodevelopmental outcome of infants enrolled in a randomized multi-center ...
Contains fulltext : 53621.pdf (publisher's version ) (Closed access)Guidelines for...
OBJECTIVE. The aim was to determine whether inhaled nitric oxide therapy improves neurodevelopmental...
Ventilated preterm infants frequently develop bronchopulmonary dysplasia (BPD) which is associated w...
Inhaled nitric oxide (iNO) is approved by the Food andDrug Administration for the treatment of persi...
The 21st century began with the FDA approval of inhaled nitric oxide therapy for the treatment of ne...
Aim: To test the hypothesis that inhaled nitric oxide therapy can decrease the incidence of bronchop...
ObjectiveInhaled nitric oxide (iNO) is a potential new therapy for prevention of bronchopulmonary dy...
Background: Respiratory failure in term and near term infants is often associated with persistent pu...
Background: Preterm infants requiring assisted ventilation are at significant risk of both pulmon...
BACKGROUND: Inhaled nitric oxide (iNO) is used widely in newborn infants with hypoxic respiratory fa...
BACKGROUND: Inhaled nitric oxide (iNO) is an effective therapy for pulmonary hypertension and hypoxi...
In animal models, inhaled nitric oxide improved gas exchange and lung structural development, but it...
The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitri...
OBJECTIVE. We compared serial measurements of inflammatory mediators and markers in infants treated ...
Objective—To report the neurodevelopmental outcome of infants enrolled in a randomized multi-center ...
Contains fulltext : 53621.pdf (publisher's version ) (Closed access)Guidelines for...
OBJECTIVE. The aim was to determine whether inhaled nitric oxide therapy improves neurodevelopmental...
Ventilated preterm infants frequently develop bronchopulmonary dysplasia (BPD) which is associated w...
Inhaled nitric oxide (iNO) is approved by the Food andDrug Administration for the treatment of persi...
DOI
Add to ORKG